Xwell Inc Stock Current Valuation
| XWEL Stock | USD 1.50 0.05 3.45% |
Valuation analysis of XWELL Inc helps investors to measure XWELL's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The value of Enterprise Value Over EBITDA is expected to slide to -0.6. The value of Enterprise Value Multiple is estimated to slide to -0.6. Fundamental drivers impacting XWELL's valuation include:
Price Book 1.2061 | Enterprise Value 3.2 M | Enterprise Value Ebitda 0.4745 | Price Sales 0.2313 | Enterprise Value Revenue 0.0944 |
Undervalued
Today
Please note that XWELL's price fluctuation is slightly risky at this time. Calculation of the real value of XWELL Inc is based on 3 months time horizon. Increasing XWELL's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the XWELL stock is determined by what a typical buyer is willing to pay for full or partial control of XWELL Inc. Since XWELL is currently traded on the exchange, buyers and sellers on that exchange determine the market value of XWELL Stock. However, XWELL's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.5 | Real 6.11 | Target 20.0 | Hype 1.51 | Naive 1.38 |
The intrinsic value of XWELL's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence XWELL's stock price.
Estimating the potential upside or downside of XWELL Inc helps investors to forecast how XWELL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of XWELL more accurately as focusing exclusively on XWELL's fundamentals will not take into account other important factors: XWELL Inc Company Current Valuation Analysis
XWELL's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current XWELL Current Valuation | 3.19 M |
Most of XWELL's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, XWELL Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
XWELL Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for XWELL is extremely important. It helps to project a fair market value of XWELL Stock properly, considering its historical fundamentals such as Current Valuation. Since XWELL's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of XWELL's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of XWELL's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, XWELL Inc has a Current Valuation of 3.19 M. This is 99.98% lower than that of the Biotechnology sector and 99.94% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.98% higher than that of the company.
XWELL Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses XWELL's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of XWELL could also be used in its relative valuation, which is a method of valuing XWELL by comparing valuation metrics of similar companies.XWELL is currently under evaluation in current valuation category among its peers.
XWELL Fundamentals
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.64) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 3.19 M | ||||
| Shares Outstanding | 5.26 M | ||||
| Shares Owned By Insiders | 9.64 % | ||||
| Shares Owned By Institutions | 17.55 % | ||||
| Number Of Shares Shorted | 71.9 K | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 0.23 X | ||||
| Revenue | 30.11 M | ||||
| Gross Profit | 12.05 M | ||||
| EBITDA | (17.23 M) | ||||
| Net Income | (27.74 M) | ||||
| Cash And Equivalents | 71.11 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 11.09 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | 3.11 X | ||||
| Cash Flow From Operations | (16.07 M) | ||||
| Short Ratio | 6.97 X | ||||
| Earnings Per Share | (3.29) X | ||||
| Price To Earnings To Growth | (0.15) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 266 | ||||
| Beta | 2.47 | ||||
| Market Capitalization | 7.6 M | ||||
| Total Asset | 38.99 M | ||||
| Retained Earnings | (455.85 M) | ||||
| Working Capital | 17.24 M | ||||
| Net Asset | 38.99 M |
About XWELL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze XWELL Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of XWELL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of XWELL Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out XWELL Piotroski F Score and XWELL Altman Z Score analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XWELL. If investors know XWELL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XWELL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.29) | Revenue Per Share 7.862 | Quarterly Revenue Growth 0.135 | Return On Assets (0.16) | Return On Equity (0.76) |
The market value of XWELL Inc is measured differently than its book value, which is the value of XWELL that is recorded on the company's balance sheet. Investors also form their own opinion of XWELL's value that differs from its market value or its book value, called intrinsic value, which is XWELL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XWELL's market value can be influenced by many factors that don't directly affect XWELL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XWELL's value and its price as these two are different measures arrived at by different means. Investors typically determine if XWELL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XWELL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.